Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07293039 · ClinicalTrials.gov registry record · NA
Gluteal Activation Plus Movement Retraining
A NA study of Lower Extremity Problem and Movement, Abnormal, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Active
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT07293039: Active NA study of Lower Extremity Problem and Movement, Abnormal, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT07293039 is a NA study of Lower Extremity Problem and Movement, Abnormal that is active but no longer recruiting, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07293039, a NA study of Lower Extremity Problem and Movement, Abnormal, is active but no longer recruiting, sponsored by Louisiana State University Health Sciences Center Shreveport.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if an isometric gluteal activation home exercise program (HEP) combined with a movement retraining program utilizing feedback cues produces significant changes in scores on the Forward Step-Down Test (FSDT) in healthy young adults with movement coordination impairments. Aim 1: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces significant changes on scores FSDT compared to the gluteal activation HEP alone. Aim 2: To determine if an isometric gluteal activation HEP followed with a movement retraining program with feedback cues produces significant changes on category FSDT compared to gluteal activation HEP alone. Aim 3: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces changes in the peak activation of the gluteus medius (GMed) and gluteus maximus (GMax) during the FSDT compared to the gluteal activation HEP alone. Aim 4: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces changes in the mean activation of the GMed and GMax during the FSDT compared to the gluteal activation HEP alone. Aim 5: To determine if HEP dose has an effect on the FSDT response, as measured by change in score on the FSDT.
Primary Outcome
Rating on the FSDT (0-6; 0-1 = good movement quality, 2-3 = moderate movement quality, 4 or more = poor movement quality).
Conditions Studied
Interventions
- OTHER Control HEP focusing on isometric gluteal activation
- OTHER Experimental HEP focusing on isometric gluteal activation plus a movement retaining program
Study Locations (1)
Louisiana
- LSU Health Sciences Center at Shreveport - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2026-01-07 |
| Est. Completion | 2026-08 |
| Phase | NA |
What the registry record for NCT07293039 still lists
NCT07293039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Lower Extremity Problem appearing as the primary indexed condition, and to 2 interventions - of which Control HEP focusing on isometric gluteal activation is the first listed.
NCT07293039 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT07293039 about?
NCT07293039 is a clinical study titled "Gluteal Activation Plus Movement Retraining". The purpose of this study is to determine if an isometric gluteal activation home exercise program (HEP) combined with a movement retraining program utilizing feedback cues produces significant changes in scores on the Forward Step-Down Test (FSDT) in healthy young adults with movement coordination ...
What is the current status of trial NCT07293039?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2026-01-07. Estimated completion is 2026-08.
What conditions does trial NCT07293039 study?
This clinical trial studies the following conditions: Lower Extremity Problem, Movement, Abnormal.
What interventions are being tested in trial NCT07293039?
The interventions under investigation include: Control HEP focusing on isometric gluteal activation (OTHER), Experimental HEP focusing on isometric gluteal activation plus a movement retaining program (OTHER).
Who is sponsoring clinical trial NCT07293039?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07293039 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Extremity Problem
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07293039's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI